Autres langues Circio Holding ASA

Actions

TRVX

NO0013033795

Recherche biotechnologique et médicale

Temps réel Oslo Bors Autres places de cotation 12:59:57 28/07/2026			Varia. 5j.	Varia. 1 janv.
9,240 ^NOK	-1,28%		+6,84%	+692,10%

16/07	Circio Holding signe une collaboration de recherche sur la sécrétion de protéines avec Avenue Biosciences	MT
16/07	Circio Holding ASA et Avenue Biosciences annoncent une collaboration de recherche pour optimiser la sécrétion de protéines en thérapie génique	CI

Autres langues

02:21	Certain Ordinary Shares of Circio Holding ASA are subject to a Lock-Up Agreement Ending on 28-JUL-2026.
16/07	Circio Holding Signs Protein Secretion Research Collaboration with Avenue Biosciences
16/07	Circio : and Avenue Biosciences jointly announce research collaboration to enhance protein secretion for gene therapy
16/07	Circio Holding ASA And Avenue Biosciences Jointly Announce Research Collaboration To Enhance Protein Secretion For Gene Therapy
24/06	Circio Holding, Tcelltech Collaborate on CAR-T Cell Therapy Research
24/06	Circio Holding ASA and Tcelltech GmbH Jointly Announces CAR-T Cell Therapy Research Collaboration
10/06	Circio Raises NOK300 Million Via Share Placing, Exercise of Warrants
10/06	Circio Raises NOK300 Via Share Placing, Exercise of Warrants
01/06	Circio Holding ASA and GenAssist Ltd Announce Gene Therapy Research Collaboration for Muscle Diseases and in Vivo Cell Therapy
01/06	Circio : and GenAssist jointly announce gene therapy research collaboration for muscle diseases and in vivo cell therapy
01/06	Circio, Genassist jointly announce gene therapy research collaboration
27/05	Circio, AaviGen Team Up on Heart Gene Therapy Research
27/05	Circio and Aavigen to collaborate on in heart gene therapy
27/05	Circio Holding ASA And AaviGen Gmbh Jointly Announce Research Collaboration To Advance Novel Gene Therapies For Heart Diseases
26/05	Circio commences exercise period for warrants
21/05	Circio Holding ASA Files EPO Patent Application Covering Critical Aspects of Its Circvec Platform for Enhanced Gene and Cell Therapy
21/05	Circio Holding files new Circvec patent application
15/05	Circio : ASGCT 2026 oral presentation
15/05	Circio : ASGCT 2026 poster
15/05	Circio : presents new and extensive circVec data at ASGCT supporting substantial AAV dose reduction
15/05	Circio Holding ASA Presents Extensive circVec Data Supporting Substantial AAV Dose Reduction At ASGCT
07/05	Circio Holding ASA: Mandatory notification of trade by primary insiders pertaining to settlement of RSUs
29/04	Circio Holding ASA and Universidad de Santiago de Compostela Enter Research Collaboration to Advance Non-Viral circVec Delivery
29/04	Circio, Traffikgene enter research collaboration
27/04	Circio Calls Off Subsequent Placement of New Shares